Publicaciones (60) Publicaciones en las que ha participado algún/a investigador/a

2015

  1. A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii

    Pharmacological Research, Vol. 97, pp. 48-63

  2. Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats

    Molecular Nutrition and Food Research, Vol. 59, Núm. 11, pp. 2326-2336

  3. Aproximación al tratamiento del envejecimiento cutáneo

    Ars pharmaceutica, Vol. 56, Núm. 4, pp. 183-191

  4. Apósitos dérmicos con agentes bioactivos especiales

    El farmacéutico: profesión y cultura, Núm. 526, pp. 26-30

  5. Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study

    Diabetes Research and Clinical Practice, Vol. 108, Núm. 3, pp. e49-e52

  6. Characterization of Iranian bentonites to be used as pharmaceutical materials

    Applied Clay Science, Vol. 116-117, pp. 193-201

  7. Characterization of patients’ requests and pharmacists’ professional practice in oropharyngeal condition in Spain

    International Journal of Clinical Pharmacy, Vol. 37, Núm. 2, pp. 300-309

  8. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity

    Journal of Hypertension, Vol. 33, Núm. 9, pp. 1831-1844

  9. Comercio Electrónico de las farmacias online españolas: diseño web y visibilidad en la Red

    International Journal of Information Systems and Software Engineering for Big Companies: IJISEBC, Vol. 2, Núm. 1, pp. 8-27

  10. Comparación de las intervenciones de educación sanitaria y de seguimiento farmacoterapéutico enpacientes con factores de riesgo cardiovascular que acuden a una farmaciacomunitaria (Estudio FISFTES-PM)

    Atencion Primaria, Vol. 47, Núm. 3, pp. 141-148

  11. Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program

    PharmacoEconomics, Vol. 33, Núm. 6, pp. 599-610

  12. Departamentos de práctica farmacéutica en el mundo, en 2006

    Ars pharmaceutica, Vol. 56, Núm. 1, pp. 8-16

  13. Design and elaboration of freeze-dried PLGA nanoparticles for the transcorneal permeation of carprofen: Ocular anti-inflammatory applications

    Colloids and Surfaces B: Biointerfaces, Vol. 136, pp. 935-943

  14. Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 11, Núm. 3, pp. 521-530

  15. Design, development and characterization of buccal bioadhesive films of Doxepin for treatment of odontalgia

    Drug Delivery, Vol. 22, Núm. 6, pp. 869-876

  16. Development and validation of a high-performance liquid chromatography method for the quantification of ursolic/oleanic acids mixture isolated from Plumeria obtusa

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 983-984, pp. 111-116

  17. Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery

    Carbohydrate Polymers, Vol. 117, pp. 140-149

  18. Development of gastro-resistant tablets for the protection and intestinal delivery of Lactobacillus fermentum CECT 5716

    International Journal of Pharmaceutics, Vol. 487, Núm. 1-2, pp. 314-319

  19. Differences in cancer drug assessment between Spain and the United Kingdom

    European Journal of Cancer, Vol. 51, Núm. 13, pp. 1843-1852

  20. Diseño y pilotaje de un proceso estructurado para el servicio de dispensación de medicamentos

    Atencion Primaria, Vol. 47, Núm. 1, pp. 7-14